NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/21/2025
Back to search
Official data from USPTO
PEGASUS-ACM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PEGASUS-ACM
ST13
US500000098062625Class
42, 44
Filing
98062625
Registration
7657587
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
01/21/2025
Trademark type
Word
Nice classes
42, 44
Filing date
06/28/2023
Registration date
01/21/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/21/2025
Last transaction
01/21/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/12/2023
First use in commerce
01/12/2023
Drawing code
4
Owner type
99
Owner location
Zug, CH
Examiner
NOBLE, ANNIE
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Rocket Pharmaceuticals GmbH
Representatives
Danny M. Awdeh FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development of pharmaceuticals for the treatment of arrhythmogenic cardiomyopathy; medical and scientific research services in the field of arrhythmogenic cardiomyopathy; compiling patient data for research purposes in the field of pharmaceutical research and development for the treatment of arrhythmogenic cardiomyopathy
Class 44
Providing information in the field of the diagnosis and treatment of arrhythmogenic cardiomyopathy; providing information in the field of arrhythmogenic cardiomyopathy; Providing links to the web sites of others featuring information about arrhythmogenic cardiomyopathy; providing links to the web sites of others in the field of the diagnosis and treatment of arrhythmogenic cardiomyopathy
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/21/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/03/2024
PUBO
PUBLISHED FOR OPPOSITION
12/03/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/27/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/16/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/16/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/16/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
05/30/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
05/30/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/15/2024
GNRT
NON-FINAL ACTION E-MAILED
03/15/2024
CNRT
NON-FINAL ACTION WRITTEN
03/15/2024
DOCK
ASSIGNED TO EXAMINER
03/13/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/31/2023
NWAP
NEW APPLICATION ENTERED
07/01/2023
Continuous trademark protection
Get notified about every new filing that threatens PEGASUS-ACM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.